BIORQ — Biora Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $35.40m
- $0.00m
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Brief: Biora Therapeutics Approved Reverse Stock Split
Brief: Biora Therapeutics Announces Positive Nasdaq Listing Decision
Brief: Biora Therapeutics Inc Files For Resale Of Up To 96.7 Mln Shares
Biora Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Biora Therapeutics Announces Funding Agreement With Existing Investors
Biora Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Biora Therapeutics Announces Positive Clinical Trial Results For BT-600
Brief: Biora Therapeutics Inc - Company Did Not Regain Compliance With Nasdaq's Mvls Rule By June 10, 2024
Biora Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Biora Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Biora Therapeutics Files Prospectus Relates To Offer & Resale By Selling Stockholder Of Up To 10.7 Mln Shares Of Common Stock
Brief: Biora Therapeutics Issued New Patent Covering Its BioJet Liquid Jet Delivery Technology
Brief: Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
U.S. STOCKS ON THE MOVE-Guess, Crypto stocks, Liquidia
Brief: Biora Therapeutics Inc And Plaintiffs Agreed To Settle Litigation Related To Co's IPO For An Amount Of $1.0 Million In March 2024